Department


Pharmacy Practice

Assistant Professor
Focus: Ambulatory Care/Pain Management

Contact Information
(518) 694-7268
Jacqueline.Cleary@acphs.edu


Speaker Request
Jacqueline H. Cleary, Pharm.D., BCACP

EDUCATION

  • Board Certified in Ambulatory Care Pharmacy
  • PGY-2 Pain and Palliative Care Residency, Albany Stratton VA Hospital, Albany, NY
  • PGY-1 Pharmacy Practice Residency, Sentara Health System, Norfolk, VA
  • Pharm.D., Medical University of South Carolina, Charleston, SC 
  • Bachelor's of Science in Chemistry, Furman University, Greenville, SC

ACADEMIC/RESEARCH INTERESTS

  • Recent national attention to the opioid epidemic has been a subject of increasing interest. Dr. Cleary has numerous posters and publications and has presented both locally and nationally on the topic of naloxone distribution, naloxone legislation, and risk mitigation strategies to reduce opioid abuse and misuse. Her interests also include pain management, both opioid and non-opioid pharmacology, pharmacogenetics, as well as the integration of behavioral health and substance abuse management. Dr. Cleary also provides education throughout the curriculum on OTC pain management options for community pharmacists as well.

  • Dr. Cleary is also the course coordinator for the nurse practitioner pharmacotherapy course at SAGE College of Nursing

PRACTICE SITE

  • Hometown Health Centers in Schenectady, NY
  • Ambulatory Care Practice 

SELECTED PUBLICATIONS

PUBLICATIONS

Prashad N, Cleary J. Galcanezumab: A New Calcitonin Gene-Related Peptide for Treating Migraine. Pharmacy Times, November 14, 2018.

Turtoro JHennig K, Cleary J, Fudin J. Looking for UDM Guidelines? Guest blog article, PainDr.com, March 23, 2018.

Fudin J, Cleary J, Sparkes S. Opioid Analgesics. In Pain Management Secrets, Argoff C et. al., ed., Chapter 38, Pg. 210-218, Fourth Ed. Elsevier Inc., 2018.

Fudin J, Cleary J, Sparkes S. Opioid Analgesics. In Argoff C et. al., ed., Pain Management Secrets. Chapter 38. Pg. 210-218. Fourth Ed. Elsevier Inc. 2018.

Cleary J, Watson A. Review of Naloxone Products, Patient’s Candidacy, and Legislation for Pharmacists. NYS Pharmacist- Publication of PSSNY. Vol 91 (4). August 2017.

Cleary J, Brennan Michael, Fudin J. Opioid rotation from Opana ER Following FDA Call for Removal. Practical Pain Management 2017 July/August. Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/opio…

ASAM Handbook on Pain and Addiction. Section II. Diagnosing and Treating Pain and Addiction: General Principles. Chapter 9. Fudin, Cleary, Kominek, Brooks, Pham. 2017.

Fudin J, Pham T, Cleary J. Abuse-Deterrent Formulations: Clinical Applications and Utility in Chronic pain. Power-Pak C.E. Available at: https://www.powerpak.com/course/preamble/113829

Cleary J, Nicewicz K, Fudin J. Life-Saving Naloxone: Review of Currently Approved Products. Practical Pain Management 2016 September 16(7).

Atkinson TJ, Pratt Cleary J, Fudin J. 10 Pain Medication Myths: Challenges in Selecting the Appropriate Analgesic. Practical Pain Management. 2016 July/August 16(6): 63-70.

Jeffrey Fudin, BS, PharmD, FCCP, FASHP, Jacqueline Pratt Cleary, PharmD, Joseph Gottwald. Buprenoprhine, so misunderstood? Guest blog article, April 4, 2016. 

Fudin J, Pratt Cleary J, Schatman ME. The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development. Journal of Pain Research. 2016 March; 9:153-156.

Jeffrey Fudin, Jacqueline Pratt Cleary, Joseph Gottwald. A Review of Buprenorphine Products. Pharmacy Times, 3/22/2016.

Jeffrey Fudin, BS, PharmD, FCCP, FASHP, Jacqueline Pratt Cleary, PharmD, Joseph Gottwald. Breaking Bad 2.0: Is it Possible to Synthesize Oxycodone from Naloxone? March 27, 2016.

Bettinger JJ, Cleary JP, Fudin J. What is the difference between Zohydro and Hysingla—hydrocodone extended release agents? Practical Pain Management. 2016 March; 16(2): 16-19.

Jacqueline Pratt Cleary. Rest Easy - Naloxone is in the House. Letters to the Editor. Practical Pain Management 2016; 16 (1): 14.

Jeffrey Fudin, Jacqueline Pratt Cleary, Mena Raouf. Risk Tools Helps Pharmacists Qualify Patients for Take-Home Naloxone. Pharmacy Times, 12/18/2015.

Timothy Atkinson, PharmD, BCPS, Jacqueline Pratt, PharmD, Jeffrey Fudin, BS, PharmD, FCCP. Challenges in Selecting Appropriate Analgesic Therapy: Ten Medication Myths. October 2015. Accepted for Publication: Journal of Pain Medicine.

Jeffrey Fudin, BS. PharmD, FCCP, Jacqueline Pratt, PharmD, Abigail Brooks, PharmD, BCPS, Courtney Kominek, PharmD, BCPS, CPE, Thien Pharm, BS, PharmD. Screening Tools When Using Opioids for Chronic Pain- textbook chapter, American Society of Addition Medicine Pain and Addiction Manual. Publisher: Oxford Press. Completed: September 2015.

Jeffrey Fudin, BS, PharmD, FCCP, FASHP, Jacqueline Pratt, PharmD, Mena Raouf, PharmD Candidate. Are you Kidding Me? Guest blog article. Posted September 18, 2015.

Jeffrey Fudin, BS, PharmD, FCCP, Thien Pharm, BS, PharmD, Jacqueline Pratt, PharmD. Abuse Deterrent Formulations: Clinical Applications and Utility in Chronic Pain. Postgraduate Healthcare Education, LLC (“PHE”) Continuing Education. Completed: July 2015.

SELECTED PRESENTATIONS

Pharmacist Promotion of Opioid Patient Safety. Continuing Education Presented at PSSNY Mid-Year Winter Meeting. Albany, New York, January 26th, 2018.

Pain Management- Select Review. Presented at Center for Rheumatology, Albany, NY September 2017.

PharmasKnowGenetics vs. Pharmacogenetics Unveiled. PainWeek 2017, Las Vegas, NV September 7, 2017.

Interdisciplinary Integration of Next Generation Pharmacists. PainWeek 2017, Las Vegas, NV September 8, 2017.

Hot Topics for Debate in Pain Management: Risk Mitigation, Multi-modal Analgesia, and Management of Frequent Flyers to the Emergency Room. Continuing Education Presented at New York State Council of Health-system Pharmacists. Bolton Landing, New York, April 28, 2017.

A Pharmacist’s Toolkit for Pain Management – Continuing Education. Presented to Mowhawk Valley Pharmacists Association, Utica, New York. March 12, 2016.

Opioid Induced Respiratory Depression and In-Home Naloxone Use: Application of the Risk Index for Overdose or Serious Opioid Induced Respiratory Depression (RIOSORD) Tool- Continuing Education. Presented at ACPHS at 2016 Alden March Bioethics Institute Clinical Ethics Conference, Albany, New York, November 19, 2016

Pharmacist’s Role in Naloxone Education and Distribution. Presented at Rho Chi and PLS joint meeting at Albany College of Pharmacy and Health Sciences, Albany, New York November 2016

Opioid Induced Respiratory Depression and Naloxone Distribution: Application of the RIOSORD Tool- Continuing Education. Presented at ACPHS at Annual Preceptor Training Day, Albany, New York, August 2016

Risk Mitigation Strategies for Pharmacists to Combat the Opioid Epidemic- Continuing Education. Presented at Vermont Pharmacist Association (VPA) Spring Meeting, Burlington, VA, April 2016.  

Opioid Induced Respiratory Depression and Naloxone Distribution: Application of the RIOSORD Tool- Continuing Education.  Presented to VISN 2 pharmacists, students, and pharmacy support staff, Albany, NY, January 2016.

CONFERENCES AND PRESENTATIONS

Gawdat MGawdat M, Bettinger J, Cleary J, Fudin F. Analysis of Variable Morphine Milligram Equivalent (MME) Threshold Trends by State. ASHP, Anaheim CA, December 2018.

Higgins O, Cleary J. Pharmacy Driven Naloxone Distribution in Patients with High Risk for Opioid-Induced Respiratory Depression. NYS ACCP Annual Meeting, Cooperstown NY, November 2018.

Higgins O, Cleary J. Pharmacy Driven Naloxone Distribution in Patients with High Risk for Opioid-Induced Respiratory Depression. ACPHS Student Summer Research Day, Albany NY, October 2018.

Bettinger J, Cleary J, Fudin J, Wegrzyn E. False-positive 6-mono acetyl morphine (6-MAM) Saliva Test Result in a Patient Taking Morphine and Aspirin: A Case Report. Pain Week, Las Vegas NV, September 2018.

Cleary J, Joyce A, Zedler B, Thomson H, Gudin J. Risk Factors for Prescription Opioid Overdose: Is It All Substance Use Disorder? ICOO, Boston MA June 2018.

Mansour VChauhan CClark L, Cleary J. Pharmacist Driven Naloxone Distribution in a Federally Qualified Health Center through Risk Index. ICOO, Boston MA, June 2018.

Cleary J, Joyce A, Zedler B, Thomson H, Gudin J. Risk Factors for Prescription Opioid Overdose: Is It All Substance Use Disorder? AAPM, Vancouver Canada, April 2018.  

Mansour VChauhan CClark L, Cleary J. Pharmacist Driven Naloxone Distribution in a Federally Qualified Health Center through Risk Index. International Conference on Opioids (ICOO), Boston MA, June 2018.

HONORS AND ACHIEVEMENTS

PAINWeek 2016 Scholarship Recipient

PROFESSIONAL ORGANIZATION MEMBERSHIPS

  • American College of Clinical Pharmacy (ACCP)
  • Society of Palliative Care Pharmacists
  • American Pharmacists Association (APhA)
  • Phi Lambda Sigma (alumna)